May 14, 2026
Subcutaneous Peptide Delivery: Bioavailability Models
Subcutaneous peptide delivery: bioavailability data, PK models, depot formulations, and SC vs IV vs oral route comparisons in preclinical animal studies.
RESEARCH NOTES
Research.
Read →
May 6, 2026
Oral Peptide Half-Life in the GI Tract: Preclinical Data
Preclinical pharmacokinetic data on oral peptide half-life across BPC-157, GLP-1 analogs, TB-500, GHK-Cu, and Epithalon across GI tract compartment models.
May 6, 2026
Oral BPC-157 Bioavailability: Preclinical Findings
Explore oral BPC-157 bioavailability data from rodent preclinical models, covering absorption mechanisms, pharmacokinetics tables, and key research limitations.
May 6, 2026
Oral vs Injectable Peptide Research: 2026 Comparison
Oral vs injectable peptide research: preclinical comparison of bioavailability, half-life, tissue distribution, research protocol design and 2026 data.
May 6, 2026
Oral BPC-157 vs Injectable: Preclinical Stability Data
Oral BPC-157 vs injectable: direct preclinical stability comparison covering bioavailability, half-life, GI tract survival, and what animal models demonstrate.